Validation Chronic Acquired Polyneuropathy – Patient Reported Index (CAP-PRI) in Russia for CIDP patients

Validation Chronic Acquired Polyneuropathy – Patient Reported Index (CAP-PRI) in Russia for CIDP patients

Background. Chronic inflammatory demyelinating polyneuropathy (CIDP) is the most common immune‑mediated polyneuropathy. CIDP is characterized by a long‑term progressive or recurrent course of the disease and the development of neurological deficits and disability, it is important to assess the quali...

Full description

Saved in:

Bibliographic Details
Main Authors:	N. A. Suponeva, E. A. Melnik, A. S. Arestova, D. G. Yusupova, A. A. Zimin, A. B. Zaytsev, N. V. Polekhina, G. A. Gatina, Nisha Mohan Ramchandani, Pratish Bundhun, E. A. Golovneva, E. V. Gnedovskaya, D. A. Grishina
Format:	Article
Language:	Russian
Published:	ABV-press 2022-09-01
Series:	Нервно-мышечные болезни
Subjects:	chronic inflammatory demyelinating polyneuropathy linguocultural validation quality of life chronic acquired polyneuropathy – patient reported index cap‑pri russian version
Online Access:	https://nmb.abvpress.ru/jour/article/view/496
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Validation of the Medical Research Council sum score (MRCss) for use in Russian-speaking patients with chronic inflammatory demyelinating polyneuropathy
by: N. A. Suponeva, et al.
Published: (2023-03-01)

Inflammatory Neuropathy Cause and Treatment (INCAT) Scale for the assessment of disability level in patients with chronic inflammatory demyelinating polyneuropathy: linguocultural ratification in Russia
by: А. S. Arestova, et al.
Published: (2021-12-01)

Validation of the Neuropathy Impairment Score (NIS) for use in Russian-speaking patients with chronic inflammatory demyelinating polyneuropathy
by: N. A. Suponeva, et al.
Published: (2024-12-01)

Lumbosacral motor polyneuropathy
by: S. A. Malmberg, et al.
Published: (2015-02-01)

Dynamics of the incidence of acute and chronic inflammatory polyneuropathies in adults in the Leningrad region
by: E. A. Skornyakova, et al.
Published: (2021-04-01)

Steroids for Chronic Inflammatory Demyelinating Polyneuropathy
by: J Gordon Millichap
Published: (2005-03-01)

Extracorporeal therapy procedures (plasma exchange and immunoadsorption) in chronic inflammatory demyelinating polyneuropathies (CIDP)– a database analysis
by: Moritz Mahlberg, et al.
Published: (2025-07-01)

Diagnostic criteria and therapeutic implications of rapid-onset demyelinating polyneuropathies
by: Wiktoria Rałowska-Gmoch, et al.
Published: (2024-12-01)

Phenotypic heterogeneity and diagnostic features of transthyretin amyloidosis with polyneuropathy
by: S. S. Nikitin, et al.
Published: (2021-12-01)

Focal Chronic Inflammatory Demyelinating Polyneuropathy – A Case Report with Clinical Application and Validation of 2021 European Academy of Neurology/Peripheral Nerve Society Criteria
by: Fu Liong Hiew, et al.
Published: (2025-01-01)

Inflammatory demyelinating polyneuropathies and patient management during the COVID-19 pandemic. Literature review
by: R. Bunevičiūtė, et al.
Published: (2020-06-01)

The characteristics of chronic inflammatory demyelinating polyneuropathy in patients with diabetes mellitus
by: R. A. Gapeshin, et al.
Published: (2020-06-01)

Yersiniosis and acute secondary axonal sensorimotor polyneuropathy: a case report
by: A. Daškevičiūtė, et al.
Published: (2019-03-01)

Prevalence of toxic, compression-ischemic, diabetic and atherosclerotic polyneuropathy in primary population of the Kemerovo region - teleuts
by: A. V. Osipov, et al.
Published: (2013-09-01)

Electrophysiological-based automatic subgroups diagnosis of patients with chronic dysimmune polyneuropathies
by: Sara Ballanti, et al.
Published: (2025-07-01)

Patient Experience of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): A Qualitative Exploration of Signs, Symptoms, and Health-Related Quality of Life Impacts
by: Anna Roberts, et al.
Published: (2025-04-01)

PATHOGENESIS, CLINICAL AND LABORATORY FEATURES OF CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY
by: R. A. Gapeshin, et al.
Published: (2018-12-01)

Atypical variants of chronic inflammatory demyelinating polyneuropathy with benign course: a clinical observation for 8 patients without pathogenic therapy
by: D. A. Grishina, et al.
Published: (2020-08-01)

Specific features of chronic inflammatory demyelinating polyneuropathy in children
by: A. L. Kurenkov, et al.
Published: (2015-02-01)

Chronic inflammatory demyelinating polyneuropathy in adults: diagnostic approaches and first line therapy
by: N. А. Suponevа, et al.
Published: (2016-03-01)

Hereditary cerebellar ataxias with polyneuropathy
by: Svetlana Vasilyevna Kopishinskaya
Published: (2015-10-01)

The use of rituximab in the treatment of disimmune polyneuropathy: a description of clinical cases and a literature review
by: V. N. Kiselev, et al.
Published: (2019-07-01)

Brazilian consensus for diagnosis, management and treatment of transthyretin familial amyloid polyneuropathy
by: Marcus Vinicius Pinto, et al.

Electrophysiological Markers of Chemotherapy-Induced Polyneuropathy
by: Olga A. Tikhonova, et al.
Published: (2025-06-01)

Electroneuromyography for early diagnosis of diabetic distal polyneuropathy
by: Elena S. Mazurenko, et al.
Published: (2019-06-01)

Postinfectious (Varicella Zoster) Myositis and Mixed Polyneuropathy
by: Arti Muley, et al.
Published: (2019-07-01)

Peripheral polyneuropathy from electrodiagnostic tests: a 10-year etiology and neurophysiology overview
by: Renata Dal-Prá Ducci, et al.
Published: (2021-11-01)

AN UPDATE DATA ON THE TREATMENT OF CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (review of literature)
by: Roman A. Gapeshin, et al.
Published: (2019-08-01)

CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY IN CHILDREN: DIAGNOSIS AND TREATMENT
by: А.L. Kurenkov, et al.
Published: (2014-10-01)

Diabetic distal polyneuropathy: prevention, treatment and rehabilitation (review)
by: A. M. Morozov, et al.
Published: (2022-07-01)

PARAPROTEINEMIC POLYNEUROPATHY ASSOCIATED WITH MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE: СLINICAL CASE DESCRIPTION AND LITERATURE REVIEW
by: A. A. Yakovlev, et al.
Published: (2017-09-01)

Relationship between the progression of diabetic polyneuropathy and impaired circadian blood pressure variability
by: Dai Yamagami, et al.
Published: (2025-03-01)

Listeria monocytogenes associated with acute axonal polyneuropathy
by: Rita Cagigal, et al.
Published: (2025-03-01)

Genetic susceptibility of human leukocyte antigen alleles in chronic inflammatory demyelinating polyneuropathy in Korean patients
by: Soonwook Kwon, et al.
Published: (2025-07-01)

Diagnostic transcranial magnetic stimulation in children with acute inflammatory demyelinating polyneuropathy
by: V. B. Voitenkov, et al.
Published: (2016-07-01)

CLINICAL SIGNS OF CHEMOTHERAPY-INDUCED NEUROPATHY IN CANCER PATIENTS AND PHARMACOTHERAPY CORRECTION OPTIONS
by: I. A. Zolotovskayaia, et al.
Published: (2018-03-01)

Tuberculous spondylitis mimicking acute inflammatory demyelinating polyneuropathy: a rare presentation
by: N. A. Gajadeera, et al.
Published: (2025-03-01)

Diabetic polyneuropathy: pathogenesis, classification, clinical presentation, and treatment
by: Marina Valentinovna Nesterova, et al.
Published: (2013-11-01)

Small fiber damage in patients with chemo-induced polyneuropathy
by: O. A. Tikhonova, et al.
Published: (2024-03-01)

EVALUATION OF HUMAN IMMUNOGLOBULIN EFFECTIVENESS IN PATIENTS WITH SENSORYMOTOR POLYNEUROPATHY ASSOCIATED WITH MONOCLONAL GAMMAPATHY OF UNDETERMINED SIGNIFICANCE
by: A. A. Yakovlev, et al.
Published: (2018-08-01)